These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20592366)

  • 61. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
    Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
    [TBL] [Abstract][Full Text] [Related]  

  • 62. L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of
    Tremmel E; Kuhn C; Kaltofen T; Vilsmaier T; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334070
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors.
    Yang H; Holowko N; Grassmann F; Eriksson M; Hall P; Czene K
    BMC Med; 2020 Aug; 18(1):225. PubMed ID: 32838791
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Does hypothyroidism increase the risk of breast cancer: evidence from a meta-analysis.
    Wang B; Lu Z; Huang Y; Li R; Lin T
    BMC Cancer; 2020 Aug; 20(1):733. PubMed ID: 32762667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review.
    Gómez-Izquierdo J; Filion KB; Boivin JF; Azoulay L; Pollak M; Yu OHY
    BMC Endocr Disord; 2020 Jun; 20(1):83. PubMed ID: 32517676
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast Cancer.
    Shao W; Kuhn C; Mayr D; Ditsch N; Kailuweit M; Wolf V; Harbeck N; Mahner S; Jeschke U; Cavaillès V; Sixou S
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31947762
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TAAR1 levels and sub-cellular distribution are cell line but not breast cancer subtype specific.
    Pitts MS; McShane JN; Hoener MC; Christian SL; Berry MD
    Histochem Cell Biol; 2019 Aug; 152(2):155-166. PubMed ID: 31111198
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.
    Tremmel E; Hofmann S; Kuhn C; Heidegger H; Heublein S; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
    Breast Cancer (Dove Med Press); 2019; 11():87-97. PubMed ID: 30858725
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies.
    Krashin E; Piekiełko-Witkowska A; Ellis M; Ashur-Fabian O
    Front Endocrinol (Lausanne); 2019; 10():59. PubMed ID: 30814976
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.
    Fröhlich E; Wahl R
    Front Immunol; 2017; 8():521. PubMed ID: 28536577
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis.
    Fang Y; Yao L; Sun J; Yang R; Chen Y; Tian J; Yang K; Tian L
    J Endocrinol Invest; 2017 Oct; 40(10):1035-1047. PubMed ID: 28516372
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.
    Vattai A; Akyol E; Kuhn C; Hofmann S; Heidegger H; von Koch F; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Spitzweg C; Toth B; Mahner S; Jeschke U; Ditsch N
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1637-1647. PubMed ID: 28409272
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Is there an association between thyroid function abnormalities and breast cancer?
    Angelousi A; Diamanti-Kandarakis E; Zapanti E; Nonni A; Ktenas E; Mantzou A; Kontzoglou K; Kouraklis G
    Arch Endocrinol Metab; 2017; 61(1):54-61. PubMed ID: 28273204
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
    Heublein S; Mayr D; Meindl A; Angele M; Gallwas J; Jeschke U; Ditsch N
    PLoS One; 2015; 10(6):e0127072. PubMed ID: 26029931
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of thyroid diseases with primary extra-thyroidal malignancies in women: results of a cross-sectional study of 6,386 patients.
    Prinzi N; Sorrenti S; Baldini E; De Vito C; Tuccilli C; Catania A; Coccaro C; Bianchini M; Nesca A; Grani G; Mocini R; De Antoni E; D'Armiento M; Ulisse S
    PLoS One; 2015; 10(3):e0122958. PubMed ID: 25826596
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serine-727 phosphorylation activates hypothalamic STAT-3 independently from tyrosine-705 phosphorylation.
    Breit A; Besik V; Solinski HJ; Muehlich S; Glas E; Yarwood SJ; Gudermann T
    Mol Endocrinol; 2015 Mar; 29(3):445-59. PubMed ID: 25584415
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).
    de Groot S; Janssen LG; Charehbili A; Dijkgraaf EM; Smit VT; Kessels LW; van Bochove A; van Laarhoven HW; Meershoek-Klein Kranenbarg E; van Leeuwen-Stok AE; van de Velde CJ; Putter H; Nortier JW; van der Hoeven JJ; Pijl H; Kroep JR
    Breast Cancer Res Treat; 2015 Jan; 149(2):461-6. PubMed ID: 25556355
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.
    Park JW; Zhao L; Cheng SY
    Am J Cancer Res; 2013; 3(3):302-11. PubMed ID: 23841029
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.
    Ditsch N; Mayr D; Lenhard M; Strauss C; Vodermaier A; Gallwas J; Stoeckl D; Graeser M; Weissenbacher T; Friese K; Jeschke U
    Oncol Lett; 2012 Oct; 4(4):665-671. PubMed ID: 23205080
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
    Guigon CJ; Kim DW; Willingham MC; Cheng SY
    Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.